Headquartered in New Milton, UK, with offices in the UK, Republic of Ireland, US, Germany and Japan, Genetix provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis in the life science and diagnostic markets. In research, pharmaceutical and biotherapeutic development, the company's systems set industry standards for screening and selection of mammalian secretory cell lines, and for accurate selection of microbial colonies. Other systems evaluate the response of cells to potential therapeutic agents and quantify tissue biomarkers. In diagnostics, Genetix holds a leading position in genetic testing with thousands of the company's platforms used in laboratories worldwide. Through its expertise in robotics, cell and molecular biology, image analysis and interpretation, supported by a strong IP portfolio, Genetix is committed to the continual development of innovative solutions.
“Illumina has been a member of ALSSA since shortly after the company was founded in 1998. As we have grown in a market where technologies are rapidly evolving, we have found the ALSSA meetings and the many opportunities for dialogue with other companies and senior executives to be an invaluable benefit of the association.”